Our series of research revealed oncogenic function of DKK3 in HNSCC/OSCC, and we developed complementary peptides that bind to the CRDs of DKK3 and inhibit the function of DKK3 [19-21]. The gene discussed is DKK3; the disease is head and neck squamous cell carcinoma.